Search Results 41-50 of 17047 for Lupus
Clinical Trials · Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V · More about research at Mayo Clinic.
Lupus: Can it cause hair loss? Fiber supplements: Safe to take every day? Organic baby food: Better for baby? Ovarian cysts and fertility: Is there a ...
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis ... Lupus Nephritis (LN).
Diagnosis of discoid/subacute cutaneous lupus erythematosus (DLE/SCLE) for at least 3 months prior to screening visit. · Meets both clinical and ...
Mayo Clinic Radio: Awareness Saturday — Arthritis / Osteoporosis / Lupus. By. Jennifer O'Hara. May 19, 2016 ...
This story originally appeared on the In the Loop blog. Regan Birr was diagnosed with lupus when she was 21 years old. In the years since, she tells us her ...
Lupus rash. Lupus is an inflammatory disorder that affects a number of body systems. One symptom is the appearance of a bumpy rash on areas of skin exposed ...
Diagnosis, evaluation and management of systemic lupus erythematosus and antiphospholipid syndrome. Complex evaluation and coordination of care for patients ...
These disorders include lupus, which can affect multiple body systems, and Sjogren's syndrome, which causes severe dryness of the mouth and eyes. Transverse ...
Anifrolumab-fnia injection is used to treat moderate to severe systemic lupus erythematosus (SLE) in patients who are also receiving other lupus treatments.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.